Log in
NASDAQ:FLKS

Flex Pharma Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
$0.68
0.00 (0.00 %)
(As of 11/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$0.67
Now: $0.69
$0.72
50-Day Range
$0.57
MA: $6.86
$14.51
52-Week Range
$0.26
Now: $0.69
$1.49
Volume472,996 shs
Average Volume2.03 million shs
Market Capitalization$12.38 million
P/E RatioN/A
Dividend YieldN/A
Beta1.65
Flex Pharma, Inc., a biotechnology company, develops and commercializes products for the treatment of muscle cramps, spasms, and spasticity associated with neurological conditions and exercise-associated muscle cramps in the United States. It operates in two segments, Consumer Operations and Drug Development. The company's lead drug candidate is FLX-787, a single molecule, chemically synthesized, and dual transient receptor potential V1/A1 ion channel activator, which completed an exploratory Phase II clinical trial in Australia for the treatment of patients with multiple sclerosis. It also offers HOTSHOT, a consumer beverage to prevent and treat exercise associated muscle cramps. The company markets and sells its HOTSHOT products online through its direct-to-consumer Website and through third-party Websites, including a retailer that offers international shipping. Flex Pharma, Inc. was founded in 2014 and is headquartered in Boston, Massachusetts.
Read More
Flex Pharma logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.58 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:FLKS
CUSIPN/A
Phone617-874-1821
Employees4

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$840,000.00
Book Value$0.51 per share

Profitability

Net Income$-21,920,000.00
Net Margins-1,208.42%

Miscellaneous

Market Cap$12.38 million
Next Earnings DateN/A
OptionableOptionable

Receive FLKS News and Ratings via Email

Sign-up to receive the latest news and ratings for FLKS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Flex Pharma (NASDAQ:FLKS) Frequently Asked Questions

What stocks does MarketBeat like better than Flex Pharma?

Wall Street analysts have given Flex Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Flex Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Flex Pharma's earnings last quarter?

Flex Pharma Inc (NASDAQ:FLKS) announced its quarterly earnings results on Wednesday, May, 1st. The biotechnology company reported ($0.12) earnings per share for the quarter. The biotechnology company earned $0.11 million during the quarter. Flex Pharma had a negative net margin of 1,208.42% and a negative return on equity of 98.04%.
View Flex Pharma's earnings history
.

Who are some of Flex Pharma's key competitors?

What other stocks do shareholders of Flex Pharma own?

Who are Flex Pharma's key executives?

Flex Pharma's management team includes the following people:
  • Dr. William K. McVicar, Pres, CEO & Director (Age 61)
  • Dr. Roderick MacKinnon, Co-Founder & Co-Chair of Scientific Advisory Board (Age 63)
  • Mr. John McCabe, CFO, Treasurer & Sec. (Age 49)
  • Dr. Thomas C. Wessel, Outside Advisor (Age 63)
  • Dr. Bruce Bean, Co-Founder, Co-Chair of Scientific Advisory Board & Board Observer

When did Flex Pharma IPO?

(FLKS) raised $60 million in an IPO on Thursday, January 29th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Jefferies and Piper Jaffray served as the underwriters for the IPO and JMP Securities, Cantor Fitzgerald and Roth Capital Partners were co-managers.

What is Flex Pharma's stock symbol?

Flex Pharma trades on the NASDAQ under the ticker symbol "FLKS."

What is Flex Pharma's stock price today?

One share of FLKS stock can currently be purchased for approximately $0.69.

How big of a company is Flex Pharma?

Flex Pharma has a market capitalization of $12.38 million and generates $840,000.00 in revenue each year. Flex Pharma employs 4 workers across the globe.

What is Flex Pharma's official website?

The official website for Flex Pharma is www.flex-pharma.com.

How can I contact Flex Pharma?

Flex Pharma's mailing address is 31 St. James Avenue 6thFloor, Boston MA, 02116. The biotechnology company can be reached via phone at 617-874-1821 or via email at [email protected]

This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.